Helmut Jeggle
Chairman presso BIONTECH SE
Patrimonio netto: 141 M $ in data 31/03/2024
Provenienza dei contatti di primo grado di Helmut Jeggle
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
20
| Public Company | Biotechnology | 20 |
18
| Public Company | Biotechnology | 18 |
12
| Public Company | Recreational Products | 12 |
IQM Finland Oy
 IQM Finland Oy Information Technology ServicesTechnology Services IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland.
10
| Holding Company | Information Technology Services | 10 |
CorTec GmbH
 CorTec GmbH Medical SpecialtiesHealth Technology CorTec GmbH develops a neuro-technological platform for brain activity measurement and stimulation. The firm specializes in the designing a platform based on the CorTec Brain Interchange technology, with focus on opening up therapeutic and diagnostic possibilities. Its application areas encompass treatment, rehabilitation, and assistance technique. The firm also engages in research and development partnerships that deal with technology development programs and funding initiatives. The company was founded by Thomas Stieglitz, Wolfgang Meier, Christina Schwartz, Jorn Rickert, Markus Raab, Christian Henle, Martin Schuttler, and Jorg Fischer in September 2010 and is headquartered in Freiburg, Germany.
5
| Holding Company | Medical Specialties | 5 |
ATS Beteiligungsverwaltung GmbH
 ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies.
4
| Subsidiary | Investment Managers | 4 |
Salvia GmbH
 Salvia GmbH Investment ManagersFinance Salvia GmbH (Salvia) is a venture capital firm founded in 2014 by Helmut Jeggle. The firm is headquartered in Holzkirchen, Germany.
3
| Private Company | Investment Managers | 3 |
AiCuris GmbH & Co. KG
 AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Solaris Pharma Corp.
 Solaris Pharma Corp. Pharmaceuticals: MajorHealth Technology Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Neuraxpharm Holding GmbH
 Neuraxpharm Holding GmbH Investment ManagersFinance Neuraxpharm Holding GmbH engages in the acquisition and administration of investments. It also manages its own assets. The company was founded on March 2, 2009 and is headquartered in Holzkirchen, Germany.
2
| Private Company | Investment Managers | 2 |
A&T Grundstück 1 GmbH
 A&T Grundstück 1 GmbH Real Estate DevelopmentFinance A & T Grundstück 1 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Thomas Maier, Sebastian Breyer, Helmut Jeggle. The company engages in buying and selling of commercial premises & non-residential buildings.
2
| Private Company | Real Estate Development | 2 |
A&T Grundstück 2 GmbH
 A&T Grundstück 2 GmbH Real Estate DevelopmentFinance A & T Grundstück 2 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Sebastian Breyer, Helmut Jeggle, Thomas Peter Maier. The company buys and sells land, buildings, and apartments.
2
| Private Company | Real Estate Development | 2 |
Palais Berlin 1 GmbH
 Palais Berlin 1 GmbH Real Estate DevelopmentFinance Palais Berlin 1 GmbH is a German company that specializes in the buying and selling of land, buildings, and flats. The private company is based in Munich, Germany. The CEOs of the company are Thomas Maier, Helmut Jeggle, Sebastian Breyer.
2
| Private Company | Real Estate Development | 2 |
Objektgesellschaft München Jahnstraße 41 und Klenzestraße
 Objektgesellschaft München Jahnstraße 41 und Klenzestraße Real Estate DevelopmentFinance Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft München Jahnstraße 41 und Klenzestraße is a residential property rental and leasing private company based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Sebastian Breyer, Thomas Maier. The company rents and leases residential properties, buildings, and apartments.
2
| Subsidiary | Real Estate Development | 2 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.
2
| Subsidiary | Pharmaceuticals: Generic | 2 |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
 Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Objektgesellschaft Berlin Passauer Straße 5-7 mbH is a private company based in Munich, Germany. Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft Berlin Passauer Straße 5-7 mbH rents, leases, and owns land, buildings, and apartments. The German company was founded in 1997 and the CEOs are Helmut Jeggle and Thomas Peter Maier.
1
| Subsidiary | Real Estate Development | 1 |
ATHOS KG
 ATHOS KG Financial ConglomeratesFinance ATHOS KG is an investment holding German company founded in 2019. The private company is based in Holzkirchen, Germany.
1
| Subsidiary | Financial Conglomerates | 1 |
LBG 2 GmbH
 LBG 2 GmbH Real Estate DevelopmentFinance LBG 2 GmbH provides residential real estate services. The private company is based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Thomas Maier.
1
| Private Company | Real Estate Development | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Helmut Jeggle tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Eon Labs, Inc.
 Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | President Director of Finance/CFO | |
Santo Holding (Deutschland) GmbH
 Santo Holding (Deutschland) GmbH Financial ConglomeratesFinance Santo Holding (Deutschland) GmbH operates as an investment holding company with focus on drug discovery and development. The company is based in Holzkirchen, Germany. | Financial Conglomerates | Director of Finance/CFO Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
G2M Cancer Drugs AG
 G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The private company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Technische Universität München | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations. | Investment Managers | Corporate Officer/Principal Chief Investment Officer | |
| The Johannes Gutenberg University of Mainz | College/University | Corporate Officer/Principal Undergraduate Degree | |
Vanguard AG
 Vanguard AG Miscellaneous Commercial ServicesCommercial Services Vanguard AG engages in the development, manufacture, and sale of medical devices and equipment used for cardiology and endoscopy. The company was founded by Bernard Frieling and Robert Schrödel in 1998 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Chief Executive Officer | |
MIG Verwaltungs AG
 MIG Verwaltungs AG Investment ManagersFinance MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved. | Investment Managers | Founder Private Equity Investor | |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Medical/Nursing Services | Director/Board Member Chairman | |
Athos Service GmbH
 Athos Service GmbH Financial ConglomeratesFinance Athos Service GmbH operates as an investment company which focuses on the pharmaceutical business. It offers personal investment trust management services. The firm also provides financial advisory services. The company is headquartered in Munich, Germany. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
AMSilk GmbH
 AMSilk GmbH TextilesProcess Industries AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany. | Textiles | Director/Board Member Director/Board Member | |
AT Newtec GmbH
 AT Newtec GmbH Financial ConglomeratesFinance AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Jossa Arznei GmbH
 Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
Hobnox GmbH
 Hobnox GmbH Internet Software/ServicesTechnology Services Hobnox GmbH engages in the development and operation of a technology platform, including corresponding applications for the use of web-based, user-generated content. It also markets and licenses out the platform, its technologies, and applications. The company was founded in 2007 and is headquartered in Munich, Germany. | Internet Software/Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
AT Impf GmbH
 AT Impf GmbH Finance/Rental/LeasingFinance AT Impf GmbH offers purchasing services. It also provides sales and acquisition services. The company was founded on November 12, 2008 and is headquartered in Munich, Germany. | Finance/Rental/Leasing | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| LSP Services Deutschland GmbH | Investment Managers | Private Equity Investor Private Equity Investor | |
| FORMYCON AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Xelesana GmbH
 Xelesana GmbH Real Estate DevelopmentFinance Xelesana GmbH provides real estate development services. The firm operates as a supplier of real estate agents and managers. The company was founded on February 27, 2008 and is headquartered in Munich, Germany. | Real Estate Development | Chief Executive Officer Chief Executive Officer | |
Biosynth Holding AG
 Biosynth Holding AG Wholesale DistributorsDistribution Services Biosynth Holding AG engages in the acquisition and holding of participating interests in firms, whose business activities include the production and distribution of chemical and biochemical products. The company was founded on January 22, 1985 and is headquartered in Staad, Switzerland. | Wholesale Distributors | Corporate Officer/Principal Director/Board Member | |
| Association For Cancer Immunotherapy | President Chairman | ||
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
| Ci3 Management UG | Chairman Founder Director/Board Member | ||
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Dr. Ernst Strüngmann Foundation gGmbH
 Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| Immunic Research GmbH | Chief Executive Officer Chief Executive Officer | ||
Armira Family SPV GmbH
 Armira Family SPV GmbH Financial ConglomeratesFinance Armira Family SPV GmbH provides investment services. The company is based in Munich, Germany. The German company was founded in 2016. The CEO is Christian Bailly. | Financial Conglomerates | Private Equity Investor Chief Executive Officer | |
AH Beteiligung 1 GmbH & Co. KG
 AH Beteiligung 1 GmbH & Co. KG Financial ConglomeratesFinance Part of Armira Verwaltungs GmbH, AH Beteiligung 1 GmbH & Co. KG is a German company that provides investment services. The company is based in Munich, Germany. The private company was founded in 2016. The CEO is Christian Bailly. | Financial Conglomerates | Private Equity Investor Chief Executive Officer | |
BioNTech Delivery Technologies GmbH
 BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The private company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
AH Beteiligung 4 GmbH & Co. KG
 AH Beteiligung 4 GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Armira Verwaltungs GmbH, AH Beteiligung 4 GmbH & Co. KG is a German company that provides economic services. The company is based in Munich, Germany. The CEO of the private company is Christian Bailly. | Miscellaneous Commercial Services | Private Equity Investor Chief Executive Officer | |
AH Beteiligung 3 GmbH & Co. KG
 AH Beteiligung 3 GmbH & Co. KG Financial ConglomeratesFinance Part of Armira Verwaltungs GmbH, AH Beteiligung 3 GmbH & Co. KG is a German company that provides financial services. The company is based in Munich, Germany. The CEO of the private company is Christian Bailly. | Financial Conglomerates | Private Equity Investor Chief Executive Officer | |
| Verinos Pharmaceuticals GmbH | Director/Board Member Director/Board Member | ||
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Germania | 42 |
| Stati Uniti | 7 |
| Austria | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 19 |
| Finance | 14 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 202 |
| Chief Executive Officer | 152 |
| Corporate Officer/Principal | 132 |
| Chairman | 58 |
| Founder | 45 |
Contatti più connessi
| Insiders | |
|---|---|
| Jörg Neermann | 34 |
| Ulrich Wandschneider | 25 |
| Thomas Werner | 25 |
| Manfred Rüdiger | 22 |
| Alexander Schemann | 22 |
| Alexander Kudlich | 20 |
| Jason Loveridge | 20 |
| Günter Frankenne | 19 |
| Stephanie Caspar | 17 |
| Clemens M. Doppler | 17 |
| Bernhard Hampl | 17 |
| Irina Antonijevic | 17 |
| Thomas Strüngmann | 16 |
| Anna Dimitrova | 16 |
| Helga Rübsamen-Schaeff | 16 |
- Borsa valori
- Insiders
- Helmut Jeggle
- Connessioni Società
